Biomarkers and prognostic factors of PD-1/PD-L1 inhibitor-based therapy in patients with advanced hepatocellular carcinomaNan Zhang, Haitao Zhao, Jiashuo Chao et al.|Biomarker Research|2024Cited by 82
Real-world efficacy and prognostic factors of lenvatinib plus PD-1 inhibitors in 378 unresectable hepatocellular carcinoma patientsXu Yang, Haitao Zhao, Jie Shi et al.|Hepatology International|2023Cited by 60
Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinomaXu Yang, Haitao Zhao, Wenjin Liu et al.|BMC Medicine|2024Cited by 43